Holen Sie sich die Stockscreener-App
0.8295
8.08%
-0.0729
Handel nachbörslich:
.86
0.0305
+3.68%
Schlusskurs vom Vortag:
$0.9024
Offen:
$0.9101
24-Stunden-Volumen:
460.55K
Relative Volume:
0.84
Marktkapitalisierung:
$11.27M
Einnahmen:
$356.60K
Nettoeinkommen (Verlust:
$-24.32M
KGV:
-0.0898
EPS:
-9.24
Netto-Cashflow:
$-27.24M
1W Leistung:
-12.73%
1M Leistung:
-44.70%
6M Leistung:
-58.73%
1J Leistung:
-43.18%
1-Tages-Spanne:
$0.8125
$0.938
1-Wochen-Bereich:
$0.73
$1.09
52-Wochen-Spanne:
$0.73
$11.18
Geovax Labs Inc Stock (GOVX) Company Profile
Firmenname
Geovax Labs Inc
Sektor
Branche
Telefon
678-384-7220
Adresse
1900 LAKE PARK DRIVE, SMYRNA
Vergleichen Sie GOVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.8295 | 11.27M | 356.60K | -24.32M | -27.24M | -9.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Bestätigt | Alliance Global Partners | Buy |
| 2025-04-15 | Bestätigt | D. Boral Capital | Buy |
| 2024-11-11 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-16 | Eingeleitet | ROTH MKM | Buy |
| 2020-11-19 | Eingeleitet | Maxim Group | Buy |
Geovax Labs Inc Aktie (GOVX) Neueste Nachrichten
Alliance Global Partners Cuts GeoVax Labs (NASDAQ:GOVX) Price Target to $8.50 - Defense World
HC Wainwright Reiterates Buy Rating for GeoVax Labs (NASDAQ:GOVX) - Defense World
Q2 EPS Estimates for GeoVax Labs Lowered by Noble Financial - Defense World
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates - Yahoo Finance
GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital - Yahoo Finance
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum - Yahoo Finance
Geovax Labs stock hits 52-week low at $0.78 amid market challenges By Investing.com - Investing.com South Africa
Top Midday Decliners - MarketScreener
These Numbers Reveal How Powerful Geovax Labs Inc (NASDAQ: GOVX) Stock Is - stocksregister.com
GeoVax Labs (GOVX) Faces Setback with Price Target Reduced by Ro - GuruFocus
GeoVax to Present at the Emerging Growth Conference on April 16, 2025 - Yahoo Finance
GeoVax (GOVX) Faces Setback with Termination of COVID-19 Vaccine Project | GOVX Stock News - GuruFocus
GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall - MarketScreener
GeoVax Labs (GOVX) Faces Setback as BARDA-Funded Trial Ends | GO - GuruFocus
Geovax Labs stock hits 52-week low at $0.78 amid market challenges - Investing.com Canada
GeoVax to Present Clinical Data at Upcoming April Industry Events - Yahoo Finance
GeoVax Labs (GOVX): Price Target Lowered Amid BARDA Project Pause | GOVX Stock News - GuruFocus
GeoVax to Discuss COVID-19 Vaccine Program and BARDA Contract at Emerging Growth Conference - citybuzz -
GeoVax Labs Got Written Notification From Advanced Technology International - MarketScreener
GeoVax tumbles as HHS ends mid-stage COVID vaccine trial - TradingView
GeoVax Labs contract with BARDA terminated - Investing.com
GeoVax Labs contract with BARDA terminated By Investing.com - Investing.com Canada
Geovax labs director John Spencer buys $9,800 in stock - Investing.com Australia
GeoVax Labs (NASDAQ:GOVX) Earns “Buy” Rating from D. Boral Capital - Defense World
Geovax labs director John Spencer buys $9,800 in stock By Investing.com - Investing.com Canada
Geovax labs VP John Sharkey acquires $5,940 in common stock By Investing.com - Investing.com Canada
GeoVax Labs (GOVX) Gains Favor with BARDA Contract Amid FDA Vacc - GuruFocus
Geovax labs VP John Sharkey acquires $5,940 in common stock - Investing.com Australia
GeoVax Labs, Inc. (NASDAQ:GOVX) Given Average Recommendation of “Buy” by Analysts - Defense World
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent - Yahoo Finance
Geovax Labs stock hits 52-week low at $0.95 amid challenges - Investing.com Australia
Short Interest in GeoVax Labs, Inc. (NASDAQ:GOVX) Drops By 12.3% - Defense World
GeoVax Labs CEO Makes Bold Stock Purchase! - TipRanks
Geovax labs CEO David Dodd acquires $10,800 in common stock By Investing.com - Investing.com South Africa
Geovax labs CEO David Dodd acquires $10,800 in common stock - Investing.com
Geovax Labs stock hits 52-week low at $1.09 amid market challenges - Investing.com
Roth Capital Forecasts GeoVax Labs FY2029 Earnings - Defense World
GeoVax Labs (NASDAQ:GOVX) Earns Buy Rating from D. Boral Capital - Defense World
GeoVax Labs Advances Vaccine Trials and Expands Operations - TipRanks
GeoVax Labs Earnings Call: Mixed Sentiments and Strategic Plans - TipRanks
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update - TradingView
Earnings call transcript: GeoVax Q4 2024 highlights ongoing challenges By Investing.com - Investing.com Canada
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
GEOVAX LABS Earnings Results: $GOVX Reports Quarterly Earnings - Nasdaq
GeoVax Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: GeoVax Q4 2024 highlights ongoing challenges - Investing.com
What's Next: Geovax Labs's Earnings Preview - Benzinga
GEOVAX LABS Earnings Preview: Recent $GOVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
GeoVax Labs IncEnters Placement Agency And Securities Purchase Agreements With A.G.P./Alliance Global PartnersSEC Filing - MarketScreener
GeoVax Labs Inc expected to post a loss of 77 cents a shareEarnings Preview - TradingView
Finanzdaten der Geovax Labs Inc-Aktie (GOVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):